Eleven analysts set USD 129.33 target for Addus HomeCare stock

Published on 10/17/2026 at 20:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Addus HomeCare reports results November 3, 2026. Addus HomeCare stock closed at USD 115.98 on Nasdaq October 16, 2026, while revenue grew 8.00 percent.

Analyst view and reporting date

Eleven research firms put the average 12-month target at USD 129.33 on October 16, 2026.
Second-quarter revenue reached USD 377.41 million, up 8.00 percent year over year.
Addus HomeCare will release third-quarter results on November 3, 2026.

ADUS, US0067391062, Illustration mit AI erstellt.

Eleven research firms put the average 12-month target for Addus HomeCare at USD 129.33 on October 16, 2026, according to Transcript Daily. The target stands 11.51 percent above the USD 115.98 Nasdaq closing price from October 16, 2026.

The consensus is described as Moderate Buy, with five buy ratings, one strong buy, four hold ratings and one sell rating. For investors, the split matters because the target provides an upside reference while the single sell rating highlights a more cautious counterview.

Revenue growth sets the operating base

Addus HomeCare reported second-quarter 2026 revenue of USD 377.41 million, up 8.00 percent from the same quarter a year earlier. Adjusted earnings per share came to USD 1.73, compared with a consensus estimate of USD 1.70, according to Transcript Daily. Operating cash flow reached USD 40.01 million in the quarter.

Stock position and valuation

Addus HomeCare stock closed at USD 115.98 on Nasdaq on October 16, 2026, down 0.44 percent from the prior close. Its 52-week range was USD 87.95 to USD 124.44, placing the closing price 6.79 percent below the high and 31.87 percent above the low.

The company had a market capitalization of USD 2.2 billion, a P/E ratio of 20.35 and an average trading volume of 210,271 shares as of October 16, 2026. The next scheduled catalyst is the third-quarter report, which Addus HomeCare said it will release after the market close on November 3, 2026, followed by a conference call on November 4, 2026, according to Business Wire.

What the next report must show

The November release will test whether the 8.00 percent revenue increase can continue while earnings remain above consensus. Management's reported second-quarter cash flow of USD 40.01 million gives the upcoming report a second operating yardstick beyond revenue and adjusted earnings per share.

Closing price and next date

The October 16, 2026 Nasdaq close leaves the stock below its 52-week high, while the USD 129.33 consensus target remains the clearest external valuation marker. The November 3, 2026 reporting date will provide the next scheduled company-specific update.